Carrera Capital Advisors Buys Shares of 98,010 Afya Limited $AFYA

Carrera Capital Advisors bought a new stake in shares of Afya Limited (NASDAQ:AFYA) during the 2nd quarter, Holdings Channel reports. The firm bought 98,010 shares of the company’s stock, valued at approximately $1,750,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Doma Perpetual Capital Management LLC raised its stake in shares of Afya by 4.4% in the 1st quarter. Doma Perpetual Capital Management LLC now owns 592,220 shares of the company’s stock worth $10,619,000 after buying an additional 25,111 shares in the last quarter. Perpetual Ltd raised its stake in shares of Afya by 1.8% in the 2nd quarter. Perpetual Ltd now owns 151,180 shares of the company’s stock worth $2,700,000 after buying an additional 2,730 shares in the last quarter. Goldman Sachs Group Inc. raised its stake in shares of Afya by 167.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 45,093 shares of the company’s stock worth $809,000 after buying an additional 28,226 shares in the last quarter. Cerity Partners LLC bought a new stake in shares of Afya in the 1st quarter worth $476,000. Finally, R Squared Ltd bought a new stake in shares of Afya in the 2nd quarter worth $264,000. Institutional investors own 88.02% of the company’s stock.

Afya Stock Performance

Shares of AFYA stock opened at $14.71 on Friday. The stock’s fifty day simple moving average is $15.27 and its 200-day simple moving average is $16.56. The company has a current ratio of 0.94, a quick ratio of 0.94 and a debt-to-equity ratio of 0.22. Afya Limited has a 1-year low of $13.47 and a 1-year high of $19.90. The company has a market capitalization of $1.38 billion, a price-to-earnings ratio of 11.14, a P/E/G ratio of 0.45 and a beta of 0.61.

Wall Street Analyst Weigh In

AFYA has been the topic of a number of recent research reports. Wall Street Zen cut Afya from a “strong-buy” rating to a “buy” rating in a report on Saturday, October 18th. Citigroup upgraded Afya from a “sell” rating to a “neutral” rating and decreased their target price for the stock from $16.00 to $14.00 in a report on Tuesday, July 29th. Weiss Ratings restated a “hold (c)” rating on shares of Afya in a report on Friday. Zacks Research upgraded Afya to a “hold” rating in a report on Friday, August 8th. Finally, JPMorgan Chase & Co. upgraded Afya from a “neutral” rating to an “overweight” rating and lifted their price target for the company from $23.50 to $24.50 in a report on Monday, September 8th. Three analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $18.20.

About Afya

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.